Our Products

Help Shape Patient Care Worldwide

As a leading innovation-driven organisation, Lilly is developing a growing portfolio of pharmaceutical products focused on meeting some of the world's most urgent medical needs in the fields of Cardiovascular, Diabetes, Men's health, Musculoskeletal, Neuroscience and Oncology.

Australian laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information on our products to speak to their healthcare professional.

The product information on this website is intended for Australian residents, if you're after our New Zealand Products page please click here.

 

  Cardiovascular Patient Product Information HCP Product Information HCP Starter Packs
  Adcirca® (tadalafil)
  Effient® (prasugrel)
   
  Dermatology
  Taltz ® (ixekizumab)
   
  Diabetes Patient Product Information HCP Product Information HCP Starter Packs
  Humalog® / Humalog Mix25 / Humalog Mix50 (insulin lispro) cartridges
  Humalog® / Humalog Mix25 / Humalog Mix50 (insulin lispro) Kwikpen
  Humalog® / Humalog Mix25 / Humalog Mix50 (insulin lispro) vials
  Humalog® U200 KwikPen®
  Humulin® (biosynthetic human insulin) vials
Trulicity® (dulaglutide)
   
  Diabetes – In alliance with Boehringer Ingelheim Patient Product Information HCP Product Information HCP Starter Packs
  Jardiance®* (empagliflozin)
  Jardiamet ®* (empagliflozin / metformin hydrochloride)
  Trajenta®* (linagliptin)
  Trajentamet®* (linagliptin and metformin hydrochloride)
Glyxambi®* (empagliflozin/linagliptin)
  * A licensed trademark of Boehringer Ingelheim    
   
  Men's Health Patient Product Information HCP Product Information HCP Starter Packs
  Cialis® (tadalafil)
   
  Musculoskeletal Patient Product Information HCP Product Information HCP Starter Packs
  Evifyne® (raloxifene hydrochloride)
  Evista® (raloxifene hydrochloride)
  Forteo® (teriparatide of recombinant DNA origin)
  Humatrope® (somatropin)
   
  Neuroscience Patient Product Information HCP Product Information HCP Starter Packs
  Andepra® (duloxetine hydrochloride) - Product no longer available
  Cymbalta® (duloxetine hydrochloride)
  Emgality® (galcanezumab)
  Prozac® (fluoxetine hydrochloride)
  Strattera® (atomoxetine hydrochloride)
  Zyprexa® (olanzapine) - Tablets and Wafers
  Zyprexa® IM (olanzapine) - Injection
  Zyprexa® Relprevv (olanzapine) long acting injectable
   
  Oncology Patient Product Information HCP Product Information HCP Starter Packs
  Alimta® (pemetrexed)
  Cyramza® (ramucirumab)
Rheumatology
Olumiant® (baricitinib)
  Taltz ® (ixekizumab)

PI

The Australian Therapeutic Goods Association (TGA) regularly issues safety alerts about counterfeit medicines that may have been unknowingly purchased by consumers via the internet or overseas. Click here to find out more.